1/3

ERLOCIP 150MG

Melizza Lifescience logo
Melizza Lifescience
Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup — Rajkot, Gujarat, India · Replies in ~24–48 hours
Export Ready
Price on request In stock
Inclusive of all taxes
MOQ: 1 Centimetre
Lead time: On request
GST invoice
Origin: India
Export ready
Buyer protection
Interested in this product?
Share your requirement and the seller will respond with a quote.
Comparing multiple suppliers?
Receive quotations from multiple verified suppliers and compare price & lead time.
Other buying options
Buyer-protected enquiry Seller responds in ~24–48 hours Freight & duties quoted separately
Export Snapshot
Minimum order
1 Centimetre
HSN Code
On request
Origin
India
Lead time
On request
Port of dispatch
On request
Packaging
Standard export packaging
Shelf life / storage
As per product specification
Export markets served
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
Ability to customise
As per OEM brief
Values shown are for Melizza Lifescience.
Company Melizza Lifescience
Melizza Lifescience logo
Melizza Lifescience

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals › Drugs & Pharmaceuticals.

View profile →
Established
Not shared
Employees
–
GST
24GQFPM5460R1Z4
IEC code
GQFPM5460R
Export markets
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
Member since
Aug 2025
Turnover
On request
Incorporation type
On request
Product details

Mechanism of Action:

• Erlotinib selectively inhibits the tyrosine kinase activity of the EGFR receptor.

• Prevents phosphorylation and downstream signaling, leading to inhibition of cancer cell proliferation and induction of apoptosis.


Dosage & Administration:

• 150 mg once daily on an empty stomach (at least 1 hour before or 2 hours after meals).

• For pancreatic cancer: 100 mg once daily (with gemcitabine).

• Dose adjustments may be required based on tolerance and side effects.


Key Benefits:

• Oral targeted therapy – no hospital infusion required.

• Effective in EGFR mutation–positive lung cancers.

• Can improve survival and quality of life in advanced cancers.


Packaging:

• Box / Blister pack of 30 tablets (150 mg each).


Storage:

• Store below 30°C, in a dry place.

• Protect from light and moisture.


Important Notes:

• For use under strict oncologist supervision only.

• Common side effects: rash, diarrhea, loss of appetite, fatigue.

• Smoking reduces drug effectiveness – patients should stop smoking.

• Liver and kidney function should be monitored during treatment.

• Not recommended in pregnancy or breastfeeding.


Melizza Lifescience

Description provided by Melizza Lifescience.

Erlotinib 150 mg

EGFR Tyrosine Kinase Inhibitor (Targeted Therapy)

NSCLC with EGFR mutations, locally advanced/metastatic NSCLC post-chemotherapy, pancreatic cancer in combination with gemcitabine

Oral tablet

150 mg once daily (NSCLC); 100 mg once daily with gemcitabine (Pancreatic cancer)

Blister pack of 30 tablets

Below 30°C, dry place, protected from light and moisture

Cipla Ltd.

Rash, diarrhea, appetite loss, fatigue

Requires oncologist supervision; smoking reduces effectiveness

Specifications
Generic Name
Erlotinib
Dosage Strength
150 mg per tablet
Formulation
Tablet
Pharmacological Action
EGFR tyrosine kinase inhibitor that blocks cancer cell proliferation and induces apoptosis
Therapeutic Area
Oncology - Targeted Cancer Therapy
Indications
Non-Small Cell Lung Cancer, Pancreatic Cancer
Recommended Dose
150 mg once daily for NSCLC, 100 mg daily with gemcitabine for pancreatic cancer
Route of Administration
Oral
Storage Instructions
Store below 30°C in dry place, protect from light and moisture
Manufacturer
Cipla Ltd.
Packaging Details
Box or blister pack containing 30 tablets
Contraindications
Pregnancy and breastfeeding
Monitoring Requirements
Liver and kidney function tests advised during therapy
Drug Interactions
Smoking reduces effectiveness; monitor patient status closely
Use cases
Category
Pharmaceuticals > Oncology Drugs > Targeted Therapy > EGFR Tyrosine Kinase Inhibitors
Primary application
Brand
Not specified
Product type
Product
Logistics & handling
Lead time
On request
Packaging
As per buyer requirement
Storage condition
As recommended by supplier
Origin
India
Form
As listed by supplier
Commercials Melizza Lifescience
Minimum order
1 Centimetre
Lead time
On request
Payment terms
As per negotiated commercial agreement
Frequently asked by buyers
Can Erlocip 150mg be used as a first-line treatment for NSCLC?

Yes, Erlocip 150mg is indicated as a first-line treatment for patients with non-small cell lung cancer (NSCLC) who have confirmed EGFR mutations.

What is the recommended dosage of Erlocip 150mg for pancreatic cancer?

For pancreatic cancer, Erlocip is administered at 100 mg once daily in combination with gemcitabine, differing from the 150 mg dosage used for NSCLC.

Are there any special storage requirements for Erlocip 150mg tablets?

Yes, Erlocip tablets should be stored below 30°C in a dry place and protected from light and moisture to maintain stability.

Is Erlocip 150mg suitable for patients who smoke?

Smoking has been shown to reduce the effectiveness of Erlocip; therefore, patients are advised to cease smoking during treatment.

What monitoring is essential during Erlocip 150mg therapy?

Liver and kidney function should be closely monitored throughout treatment with Erlocip to detect any potential adverse effects.

What common side effects should be anticipated with Erlocip 150mg?

Common side effects include rash, diarrhea, loss of appetite, and fatigue; patients should report any severe or persistent symptoms to their healthcare provider.

Question not answered? Sellers typically reply within 24–48 hours.

What similar products are available in this category?

Browse all →
surbhi herbal tea - an ayurvedic formulation
surbhi herbal tea - an ayurvedic formulation
Hetha
From $ 5.44
MOQ 1 Centimetre
brahmi ghrita nasal drop
brahmi ghrita nasal drop
Hetha
From $ 5.10
MOQ 1 Centimetre
himalayan badri gaumutra (gomutra) ark
himalayan badri gaumutra (gomutra) ark
Hetha
From $ 3.97
MOQ 1 Centimetre
triphala gaumutra ark
triphala gaumutra ark
Hetha
From $ 3.97
MOQ 1 Centimetre
desi cow gaumutra ark / gomutra ark
desi cow gaumutra ark / gomutra ark
Hetha
From $ 3.40
MOQ 1 Centimetre
parijat aloevera gaumutra ark
parijat aloevera gaumutra ark
Hetha
From $ 3.97
MOQ 1 Centimetre
kachnar gaumutra ark
kachnar gaumutra ark
Hetha
From $ 3.97
MOQ 1 Centimetre
tulsi giloy gaumutra ark
tulsi giloy gaumutra ark
Hetha
From $ 3.97
MOQ 1 Centimetre

More from Melizza Lifescience

View all →
remtrex 2.5mg, 15mg,
remtrex 2.5mg, 15mg,
Price on request
MOQ 1 Centimetre
gemdronic 5mg
gemdronic 5mg
Price on request
MOQ 1 Centimetre
gemdronic 5mg
gemdronic 5mg
Price on request
MOQ 1 Centimetre
altanib nova imatinib 400mg tablets
altanib nova imatinib 400mg tablets
Price on request
MOQ 1 Centimetre
lucrin depot 3.75 mg / 11.25 mg injection
lucrin depot 3.75 mg / 11.25 mg injection
Price on request
MOQ 1 Centimetre
truvada-tablets
truvada-tablets
Price on request
MOQ 1 Centimetre
abstet 250mg tablet (abiraterone acetate (250mg))
abstet 250mg tablet (abiraterone acetate (250mg))
Price on request
MOQ 1 Piece
capeta nova 500mg
capeta nova 500mg
Price on request
MOQ 1 Centimetre
ERLOCIP 150MG
ERLOCIP 150MG
Price on request